World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
84
Citations
29963
World Ranking
909
National Ranking
420

Cornelius J. Clancy publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Cornelius J. Clancy sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 363 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Cornelius J. Clancy D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Cornelius J. Clancy sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 84 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Cornelius J. Clancy is affiliated with the University of Pittsburgh in the United States. Their research primarily focuses on fields related to medicine, with particular emphasis on infectious diseases and epidemiology. Their body of work spans interdisciplinary areas including biochemistry, genetics, molecular biology, applied microbiology and biotechnology, molecular medicine, and clinical biochemistry.

The scientist has contributed extensively to the study of antimicrobial resistance, with key topics of their research including antifungal resistance and susceptibility, antibiotic use and resistance, antibiotic resistance in bacteria, bacterial identification and susceptibility testing, fungal infections and studies, antibiotics pharmacokinetics and efficacy, and Pneumocystis jirovecii pneumonia detection and treatment.

Frequent co-authors collaborating with Cornelius J. Clancy include:

  • M. Hong Nguyen
  • Shaoji Cheng
  • Deanna J. Buehrle
  • Ryan K. Shields

Publication venues where Cornelius J. Clancy has frequently published are:

  • Open Forum Infectious Diseases
  • Clinical Infectious Diseases
  • Antimicrobial Agents and Chemotherapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Intensive Care Medicine

Among recent publications authored or co-authored by Cornelius J. Clancy are:

  • Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections, 2023, Clinical Infectious Diseases
  • Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections, 2021, Clinical Infectious Diseases
  • Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa), 2022, Clinical Infectious Diseases
  • Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion, 2020, Intensive Care Medicine
  • Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa), 2020, Clinical Infectious Diseases

Best Publications

  • Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

    Peter G. Pappas;Carol A. Kauffman;David R. Andes;Cornelius J. Clancy

  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach

  • Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

    Peter G. Pappas;Carol A. Kauffman;David R. Andes;Cornelius J. Clancy

  • Finding the “Missing 50%” of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care

    Cornelius J. Clancy;M. Hong Nguyen

  • Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.

    Unknown

  • Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections.

    Unknown

  • Pharmacokinetic/Pharmacodynamic Profile of Posaconazole

    Ursula Theuretzbacher;Franziska Ihle;Hartmut Derendorf

  • Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).

    Unknown

  • Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia.

    Ryan K. Shields;M. Hong Nguyen;Liang Chen;Ellen G. Press

  • Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.

    Ryan K. Shields;Liang Chen;Shaoji Cheng;Kalyan D. Chavda

  • T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial

    Eleftherios Mylonakis;Cornelius J. Clancy;Luis Ostrosky-Zeichner;Kevin W. Garey

  • Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections.

    Ryan K. Shields;Brian A. Potoski;Ghady Haidar;Binghua Hao

  • Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and <i>Pseudomonas aeruginosa</i> with Difficult-to-Treat Resistance (DTR-<i>P. aeruginosa</i>)

    Unknown

  • Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.

    Paul E. Verweij;Bart J.A. Rijnders;Roger J.M. Brüggemann;Elie Azoulay

  • Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).

    Pranita D Tamma;Samuel L Aitken;Robert A Bonomo;Amy J Mathers

  • Performance of Candida Real-time Polymerase Chain Reaction, β-D-Glucan Assay, and Blood Cultures in the Diagnosis of Invasive Candidiasis

    M. Hong Nguyen;Mark C. Wissel;Ryan K. Shields;Martin A. Salomoni

  • Do In Vitro Susceptibility Data Predict the Microbiologic Response to Amphotericin B? Results of a Prospective Study of Patients with Candida Fungemia

    M. Hong Nguyen;Cornelius J. Clancy;Victor L. Yu;Yue C. Yu

  • Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections.

    Ryan K. Shields;M. Hong Nguyen;Liang Chen;Ellen G. Press

  • Coronavirus disease 2019, superinfections, and antimicrobial development: what can we expect?

    Cornelius J Clancy;M Hong Nguyen

  • Diagnosing Invasive Candidiasis

    Cornelius J. Clancy;M. Hong Nguyen

  • Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance.

    Ghady Haidar;Nathan J Philips;Ryan K Shields;Daniel Snyder

  • Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.

    WB Grow;JS Moreb;D Roque;K Manion

  • Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients

    Cornelius J. Clancy;Reia A. Jaber;Helen L. Leather;John R. Wingard

  • Fluconazole MIC and the Fluconazole Dose/MIC Ratio Correlate with Therapeutic Response among Patients with Candidemia

    Cornelius J. Clancy;Victor L. Yu;Arthur J. Morris;David R. Snydman

  • Candida albicans Pathogenesis: Fitting Within the “Host-Microbe Damage Response Framework”

    Mary Ann Jabra-Rizk;Eric F. Kong;Christina Tsui;M. Hong Nguyen

Frequent Co-Authors

M. Hong Nguyen
M. Hong Nguyen University of Pittsburgh
Ryan K. Shields
Ryan K. Shields University of Pittsburgh
Joseph M. Pilewski
Joseph M. Pilewski University of Pittsburgh
Barry N. Kreiswirth
Barry N. Kreiswirth Center for Discovery and Innovation
Liang Chen
Liang Chen Hackensack Meridian Health Center for Discovery and Innovation
Yohei Doi
Yohei Doi University of Pittsburgh
John R. Wingard
John R. Wingard University of Florida
Marilyn M. Wagener
Marilyn M. Wagener University of Pittsburgh
Peter G. Pappas
Peter G. Pappas University of Alabama at Birmingham
A. William Pasculle
A. William Pasculle University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open diverse career opportunities. Health information management is one such field that blends healthcare and data expertise. Understanding the health information management salary and career paths can help gauge the potential benefits of entering this growing sector.

When considering degrees, it’s important to choose programs with recognized accreditation. The best online health information management degree cahiim accredited programs ensure quality education aligned with industry standards, improving job prospects and readiness.

For those seeking shorter credential pathways, accelerated courses like the medical billing and coding certificate online accelerated programs offer quick entry into the healthcare administration workforce. These certifications complement scientific backgrounds such as microbiology by broadening skill sets.

Additionally, many students explore online medical degrees that offer flexibility and accessibility. With the rise of digital learning, combining microbiology knowledge with healthcare-focused online degrees can lead to impactful careers in research, diagnostics, and health informatics.

Best Scientists Citing Cornelius J. Clancy

Trending Scientists

Recently Published Articles